Evidence. Access. Adoption.
Bridging the gap between innovation and adoption
Great medical devices don’t fail because the technology isn’t good enough. They stall because the evidence, market access, and clinical story either weren’t built together or are not being communicated clearly. JKM Health Research helps device companies navigate the translational gap—aligning clinical evidence, value demonstration, and product messaging before the gaps become barriers.
About
Jennifer Matson is a biomedical engineer and public health professional with more than 25 years of experience spanning research & development, clinical affairs, and product innovation in the medical device industry.
Her career includes leadership roles at Biotronik, Bayer, and Acarix, working across FDA Class II and III devices as well as Humanitarian Device Exemptions. She has led clinical programs internationally and driven evidence strategies from bench to bedside.
Jennifer holds a BSc in Biomedical Engineering from Boston University and a Master of Public Health from the Johns Hopkins Bloomberg School of Public Health. She also brings experience leading program evaluation for healthcare reform initiatives funded through Medicare & Medicaid Innovation grants.
Credentials: 25+ Years Experience | Biomedical Engineering Boston University | MPH Johns Hopkins
Services
Closing the translational gap
Market Access & Value Dossiers: Market access dossiers and value propositions that articulate clinical differentiation, economic impact, and payer-relevant outcomes — giving health systems and payers a clear reason to say yes.
Claims Development & Clinical Messaging: Evidence-based claims development rooted in clinical data and regulatory boundaries. Clear, defensible language for product positioning — from mechanism of action narratives to promotional review support.
Clinical Evidence & Outcomes Strategy: Strategic planning for the clinical evidence your product needs at each stage — from early feasibility through post-market. Designed to support regulatory, reimbursement, and commercial goals simultaneously.
Medical Affairs : Advisory board design, KOL mapping, and scientific communication strategy that builds clinical credibility and supports field teams with peer-driven insights.